Unknown

Dataset Information

0

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.


ABSTRACT: Cancer occurrence in 164 families with breast/ovarian cancer and germline BRCA2 mutations was studied to evaluate the evidence for genotype-phenotype correlations. Mutations in a central portion of the gene (the "ovarian cancer cluster region" [OCCR]) were associated with a significantly higher ratio of cases of ovarian:breast cancer in female carriers than were mutations 5' or 3' of this region (P<.0001), extending previous observations. The optimal definition of the OCCR, as judged on the basis of deviance statistics, was bounded by nucleotides 3059-4075 and 6503-6629. The relative and absolute risks of breast and ovarian cancer associated with OCCR and non-OCCR mutations were estimated by a conditional likelihood approach, conditioning on the set of mutations observed in the families. OCCR mutations were associated both with a highly significantly lower risk of breast cancer (relative risk [RR] 0.63; 95% confidence interval (95% CI) 0.46-0.84; P=.0012) and with a significantly higher risk of ovarian cancer (RR = 1.88; 95% CI = 1.08-3.33; P=.026). No other differences in breast or ovarian cancer risk, by mutation position, were apparent. There was some evidence for a lower risk of prostate cancer in carriers of an OCCR mutation (RR = 0.52; 95% CI = 0.24-1.00; P=.05), but there was no evidence of a difference in breast cancer risk in males. By age 80 years, the cumulative risk of breast cancer in male carriers of a BRCA2 mutation was estimated as 6.92% (95% CI = 1.20%-38.57%). Possible mechanisms for the variation in cancer risk are suggested by the coincidence of the OCCR with the RAD51-binding domain.

SUBMITTER: Thompson D 

PROVIDER: S-EPMC1235274 | biostudies-literature | 2001 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

Thompson D D   Easton D D  

American journal of human genetics 20010119 2


Cancer occurrence in 164 families with breast/ovarian cancer and germline BRCA2 mutations was studied to evaluate the evidence for genotype-phenotype correlations. Mutations in a central portion of the gene (the "ovarian cancer cluster region" [OCCR]) were associated with a significantly higher ratio of cases of ovarian:breast cancer in female carriers than were mutations 5' or 3' of this region (P<.0001), extending previous observations. The optimal definition of the OCCR, as judged on the basi  ...[more]

Similar Datasets

| S-EPMC6926480 | biostudies-literature
| S-EPMC3107565 | biostudies-literature
| S-EPMC1856321 | biostudies-literature
| S-EPMC3887142 | biostudies-literature
| S-EPMC3516682 | biostudies-other
| S-EPMC3089675 | biostudies-literature
| S-EPMC3446398 | biostudies-literature
2012-02-01 | E-GEOD-32259 | biostudies-arrayexpress
2012-02-01 | GSE32259 | GEO
| S-EPMC4979233 | biostudies-other